+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comprehensive analysis of west nile virus-specific T cell responses in humans



Comprehensive analysis of west nile virus-specific T cell responses in humans



Journal of Infectious Diseases 197(9): 1296-1306



Cellular responses have been shown to play a role in immune control and clearance of West Nile virus (WNV) in murine models. However, little is known about the immunogenic regions of the virus or the phenotype of responding T cells in human infection. Frozen peripheral blood mononuclear cells (PBMCs) from 35 WNV-infected blood donors were screened for virus-specific T cell responses by an interferon-gamma (IFN-gamma) enzyme-linked immunosorbent spot assay that used 452 overlapping peptides spanning all WNV proteins. More-detailed phenotypic studies were performed on subjects with high-magnitude T cell responses. In individuals with identified responses, the total number of recognized WNV peptides ranged from 1 to 9 (median, 2 peptides), and the overall magnitude of responses ranged from 50 to 4210 spot-forming cells (SFCs) per 10(6) PBMCs (median, 130 SFCs/10(6) PBMCs). A subset of 8 frequently recognized peptides from the regions of the genome encoding membrane, envelope, and nonstructural 3 and 4b proteins was identified. Phenotypic study of the highest magnitude WNV-specific T cell responses revealed that most were mediated by CD8+ cells that expressed perforin and/or granzyme B. These findings are the first to define the breadth and characteristics of the human T cell response to WNV and have implications for candidate vaccine design and evaluation.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 052269933

Download citation: RISBibTeXText

PMID: 18422442

DOI: 10.1086/586898


Related references

Subcapsular sinus macrophages limit dissemination of West Nile virus particles after inoculation but are not essential for the development of West Nile virus-specific T cell responses. Virology 450-451: 278-289, 2014

Comprehensive mapping of West Nile virus WNV- and Japanese encephalitis virus serocomplex-specific linear B-cell epitopes from WNV non-structural protein. Journal of General Virology 93(1): 50-60, 2012

Comprehensive mapping of West Nile virus (WNV)- and Japanese encephalitis virus serocomplex-specific linear B-cell epitopes from WNV non-structural protein 1. Journal of General Virology 93(Pt 1): 50-60, 2012

Dynamics of Tissue-Specific CD8 + T Cell Responses during West Nile Virus Infection. Journal of Virology 92(10), 2018

A West Nile virus recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse. Veterinary Immunology And Immunopathology3: 3 4, 230-239, 2008

A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse. Veterinary Immunology and Immunopathology 123(3-4): 230-239, 2008

Cell-specific IRF-3 responses protect against West Nile virus infection by interferon-dependent and -independent mechanisms. Plos Pathogens 3(7): E106-E106, 2007

Modeling and Surveillance of Reporting Delays of Mosquitoes and Humans Infected With West Nile Virus and Associations With Accuracy of West Nile Virus Forecasts. JAMA Network Open 2(4): E193175, 2019

Performance of immunoglobulin G (IgG) and IgM enzyme-linked immunosorbent assays using a West Nile virus recombinant antigen (preM/E) for detection of West Nile virus- and other flavivirus-specific antibodies. Journal of Clinical Microbiology 42(10): 4641-4648, 2004

Recombinant vesicular stomatitis virus-based west Nile vaccine elicits strong humoral and cellular immune responses and protects mice against lethal challenge with the virulent west Nile virus strain LSU-AR01. Vaccine 27(6): 893-903, 2009

Antibody responses in humans infected with newly emerging strains of West Nile Virus in Europe. Plos One 8(6): E66507, 2014

High seroprevalence of west nile virus-specific antibodies in humans following an epidemic in Nebraska. 2006

A recombinant influenza A virus expressing domain III of West Nile virus induces protective immune responses against influenza and West Nile virus. Plos One 6(4): E18995, 2011

Comprehensive mapping of common immunodominant epitopes in the West Nile virus nonstructural protein 1 recognized by avian antibody responses. Plos One 7(2): E31434, 2012

Establishment of an Algorithm Using prM/E- and NS1-Specific IgM Antibody-Capture Enzyme-Linked Immunosorbent Assays in Diagnosis of Japanese Encephalitis Virus and West Nile Virus Infections in Humans. Journal of Clinical Microbiology 54(2): 412-422, 2016